Cargando…
Vaccine-Related adverse events following AZD1222 (ChAdOx1-nCoV-19) Covid-19 vaccine in solid malignancy patients receiving cancer treatment, as compared to age-matched healthy controls
The study aimed to evaluate vaccine-related adverse events (VRAEs) following ChAdOx1-nCoV-19 vaccine in solid cancer patients receiving treatment compared to healthy controls. 399 cancer patients and 90 healthy volunteers were enrolled. In the overall population, the incidence of VRAEs was significa...
Autores principales: | Pakvisal, Nussara, Sainamthip, Panot, Teeyapun, Nattaya, Luangdilok, Sutima, Wanlapakorn, Nassamon, Yorsaeng, Ritthideach, Poovorawan, Yong, Pakvisal, Piyapoom, Susiriwatananont, Thiti, Zungsontiporn, Nicha, Sriuranpong, Virote, Tanasanvimon, Suebpong, Wanchaijiraboon, Passakorn |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746493/ https://www.ncbi.nlm.nih.gov/pubmed/35776836 http://dx.doi.org/10.1080/21645515.2022.2094149 |
Ejemplares similares
-
Safety Following COVID-19 Booster Vaccine with BNT162b2 Compared to mRNA-1273 in Solid Cancer Patients Previously Vaccinated with ChAdOx1 or CoronaVac
por: Wanchaijiraboon, Passakorn, et al.
Publicado: (2023) -
Immunogenicity after a Third COVID-19 mRNA Booster in Solid Cancer Patients Who Previously Received the Primary Heterologous CoronaVac/ChAdOx1 Vaccine
por: Luangdilok, Sutima, et al.
Publicado: (2022) -
Durability of Immune Response to ChAdOx1-nCoV-19 Vaccine in Solid Cancer Patients Undergoing Anticancer Treatment
por: Wanchaijiraboon, Passakorn, et al.
Publicado: (2022) -
Immunogenicity of ChAdOx1-nCoV-19 vaccine in solid malignancy patients by treatment regimen versus healthy controls: A prospective, multicenter observational study
por: Teeyapun, Nattaya, et al.
Publicado: (2022) -
OP12 Durability and immunogenicity after two doses of ChAdOx1 nCov-19 among the type of cancer treatment in oncologic patients: A prospective, multicenter observational study
por: Wanchaijiraboon, P., et al.
Publicado: (2022)